Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPEā¢. The capital will enable completion of the ongoing Phase 2 clinical trial in
Funds
CSC, the worldās leading provider of global business administration and compliance solutions, is pleased to announce the expansion of its newly combined Funds and Capital Markets (FCM) division, with the strategic appointments of John Hebert and Venkat Srinivasan. The move follows CSCās announcement earlier this year that the Intertrust Group acquisition of November 2022
Commodities The reporting week saw global financial markets continue a strong rebound, with early August’s market turmoil now a distant memory. Instead, increased expectations for a September US rate cut helped drive stock markets sharply higher and the dollar and long-end US Treasury yields lower. Elsewhere, China, the world’s top consumer of commodities,












